Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Status:
Terminated
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of zalutumumab in combination with
chemotherapy and radiotherapy as treatment of patients with head and neck cancer